Spark Therapeutics Inc (ONCE):企業の財務・戦略的SWOT分析

◆英語タイトル:Spark Therapeutics Inc (ONCE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH500663FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Spark Therapeutics Inc (Spark) is a clinical-stage gene therapy company which provides gene therapies for inherited retinal diseases (IRDs), neurodegenerative diseases, as well as liver diseases. Its pipeline products include SPK-RPE65, SPK-CHM, rhonova, LHON, SPK-FIX, SPK-FVIII and SPK-TPP1. The company’s gene therapy vectors used in its programs are engineered using adeno-associated virus. Spark’s SPK-RPE65 is intentended to cure rare blinding conditions caused by mutations in the RPE65 gene. The company develops gene therapy products for the treatment of debilitating genetic diseases such as inherited retinal dystrophies, hematologic disorders and neurodegenerative diseases. It collaborates with pharma and biotech companies for its research and development activities. Spark is headquartered in Philadelphia, Pennsylvania, the US.

Spark Therapeutics Inc Key Recent Developments

Feb 25,2021: Spark Therapeutics further strengthens technical expertise with appointment of Cynthia Pussinen as Chief Technical Officer
Feb 01,2021: Spark Therapeutics Announces First Participant Dosed in Phase 1/2 Study of Investigational Gene Therapy for Late-Onset Pompe Disease
Nov 16,2020: Spark Therapeutics expands visionary leadership with appointment of Michael Retterath as Chief Strategy Officer
Aug 10,2020: Spark Therapeutics deepens drug development expertise in hematology and rare disease with appointment of Gallia G. Levy, M.D., Ph.D., as Chief Medical Officer
Jun 01,2020: Study demonstrating role of IdeS in enabling of gene therapy in the presence of neutralizing anti-AAV antibodies published in Nature Medicine

This comprehensive SWOT profile of Spark Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Spark Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Spark Therapeutics Inc – Key Information
Spark Therapeutics Inc – Overview
Spark Therapeutics Inc – Key Employees
Spark Therapeutics Inc – Key Employee Biographies
Spark Therapeutics Inc – Key Operational Heads
Spark Therapeutics Inc – Major Products and Services
Spark Therapeutics Inc – History
Spark Therapeutics Inc – Company Statement
Spark Therapeutics Inc – Locations And Subsidiaries
Spark Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Spark Therapeutics Inc – Business Description
Spark Therapeutics Inc – Corporate Strategy
Spark Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Spark Therapeutics Inc – Strengths
Spark Therapeutics Inc – Weaknesses
Spark Therapeutics Inc – Opportunities
Spark Therapeutics Inc – Threats
Spark Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Spark Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Spark Therapeutics Inc, Key Information
Spark Therapeutics Inc, Key Ratios
Spark Therapeutics Inc, Share Data
Spark Therapeutics Inc, Major Products and Services
Spark Therapeutics Inc, History
Spark Therapeutics Inc, Key Employees
Spark Therapeutics Inc, Key Employee Biographies
Spark Therapeutics Inc, Key Operational Heads
Spark Therapeutics Inc, Other Locations
Spark Therapeutics Inc, Subsidiaries
Spark Therapeutics Inc, Key Competitors
Spark Therapeutics Inc, SWOT Analysis
Spark Therapeutics Inc, Ratios based on current share price
Spark Therapeutics Inc, Annual Ratios
Spark Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Spark Therapeutics Inc (ONCE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Antisense Therapeutics Ltd (ANP):企業の財務・戦略的SWOT分析
    Antisense Therapeutics Ltd (ANP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Fujimori Kogyo Co., Ltd. (7917):企業の財務・戦略的SWOT分析
    Fujimori Kogyo Co., Ltd. (7917) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Bioverativ Inc (BIVV):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technolog …
  • Holtec International Inc:電力:M&Aディール及び事業提携情報
    Summary Holtec International, Inc. (Holtec) is a diversified energy technology company. It supplies equipment and systems for the nuclear, solar, geothermal and fossil power generation sectors of the energy industry. The company’s products and service portfolio includes advanced technology solutions …
  • Lonmin Plc:企業の戦略・SWOT・財務情報
    Lonmin Plc - Strategy, SWOT and Corporate Finance Report Summary Lonmin Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Danubius Hotel And Spa Private Company Limited:企業の戦略・SWOT・財務分析
    Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report Summary Danubius Hotel And Spa Private Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • China Taiping Insurance Holdings Company Limited:戦略・SWOT・企業財務分析
    China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Taiping Insurance Holdings Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Jaiprakash Power Ventures Ltd (JPPOWER):電力:M&Aディール及び事業提携情報
    Summary Jaiprakash Power Ventures Ltd (Jaiprakash Power) is a power utility. It plans, develops, implements, and operates electric projects. The company produces electricity using hydro and coal sources. Jaiprakash Power also has development interests in the Hirong hydroelectric project and the Lowe …
  • Computershare Limited (CPU):企業の財務・戦略的SWOT分析
    Computershare Limited (CPU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Neiman Marcus Group LTD LLC:戦略・SWOT・企業財務分析
    Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report Summary Neiman Marcus Group LTD LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Actinium Pharmaceuticals Inc (ATNM):企業の財務・戦略的SWOT分析
    Summary Actinium Pharmaceuticals Inc (Actinium), formerly Cactus Ventures Inc, is a biopharmaceutical company. It develops antibody radiation conjugates (ARC), which combine the targeting ability of antibodies with the cell killing ability of radiation. The company's pipeline products include Iomab- …
  • Theravasc Inc-製薬・医療分野:企業M&A・提携分析
    Summary Theravasc Inc (Theravasc) is a healthcare services provider that develops treatments for various chronic medical diseases using oral formulation of sodium nitrite. The company’s product TV1001SR is a coated oral formulation of sodium nitrite for the treatment of peripheral artery diseases an …
  • Taiwan High Speed Rail Corporation:企業の戦略・SWOT・財務分析
    Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiwan High Speed Rail Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Canadian Western Bank Group (CWB):企業の財務・戦略的SWOT分析
    Canadian Western Bank Group (CWB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • UMW Holdings Bhd (UMW)
    UMW Holdings Bhd (UMW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • CarMax, Inc.:戦略・SWOT・企業財務分析
    CarMax, Inc. - Strategy, SWOT and Corporate Finance Report Summary CarMax, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • P.T. Surya Toto Indonesia Tbk.:企業の戦略・SWOT・財務情報
    P.T. Surya Toto Indonesia Tbk. - Strategy, SWOT and Corporate Finance Report Summary P.T. Surya Toto Indonesia Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Jellagen Pty Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Jellagen Pty Ltd (Jellagen) is a provider of medical grade collagen products. The company’s products offer medical grade collagen supplied in the form of hydragel used in wound dressing, soft tissue regeneration, tissue engineering and haemostats. Its product pipeline offer scaffolds, which …
  • AB Volvo:企業の戦略・SWOT・財務情報
    AB Volvo - Strategy, SWOT and Corporate Finance Report Summary AB Volvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Shenzhen Kaifa Technology Co Ltd (000021):企業の財務・戦略的SWOT分析
    Shenzhen Kaifa Technology Co Ltd (000021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆